blindness from glp 1 GLP-1 meds and vision: what the scary headlines DON'T say iLIV Clinic | 👀 You've

Originally developed for type 2 diabetes management, several of these medications have received FDA approval for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with weight-related comorbidities

But promotional material for weight loss medications, according to Ms Rowlands, did not include information about potential side effects or the "unaffordable" need to be on them long-term

Alissou M, Demangeat T, Folope V, et al

26 It is also feasible that reduction in AMD risk factors such as obesity, cardiovascular disease, and hyperlipidemia with GLP-1RAs could further provide benefit by reducing systemic inflammation and vascular risk factors